Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lumora Ltd.

Division of Erba Diagnostics Mannheim GMBH
www.lumora.co.uk

Latest From OctreoPharm Sciences GMBH

Deal Watch: AbbVie Moves Into Microbiome, Synthetic Biology With Synlogic Partnership

Mylan adds more than 900 over-the-counter and generic products to its portfolio with the $9.9bn acquisition of Meda. Astellas finalizes the pursuit of Ocata which it began last November.

BioPharmaceutical Deals

Ipsen’s U.S. Business Could Be Profitable In 2016, A Year Early

A turnaround in Ipsen’s U.S. business is underpinning a transformation at the European mid-sized pharmaceutical company, which is planning to narrow its focus to niche therapeutic areas including gastrointestinal endocrine tumors and antispasticity neurotoxins.

BioPharmaceutical Consumer

European Notebook: New Pricing Models; G7 On Clinical Data Transparency; Early Access For Opdivo

Novartis’s Jimenez calls for new outcomes-based pricing in Europe, and U.K. PM Cameron wants the results of vaccine clinical trials to be open and transparent post-Ebola, while patients gain pre-approval access to Bristol’s new PD-1 inhibitor.

BioPharmaceutical Europe

Start-Up Previews, October 2013

This Month's Profile Group: Biotechs Share Endocrine Enthusiasm, features profiles of Atterocor, Crinetics Pharmaceuticals, and OctreoPharm Sciences. Plus these Start-Ups Across Health Care: Biom’Up SA, KemPharm, LIM Innovations, Reflectance Medical, and Trino Therapeutics.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • Therapeutic Areas
  • Gastrointestinal
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Erba Diagnostics Mannheim GMBH
  • Senior Management
  • Laurence Tisi, PhD, CEO
    Hayden Jeffreys, Commercial Dir.
    Rob Sprawson, Fin. Dir.
  • Contact Info
  • Lumora Ltd.
    Phone: 1353 667907
    Bartholomews Walk
    Ely, Cambridgeshire, CB7 4EA
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register